1. ABOUT US

    #

    about us

    Our business research and market analysis helps organizations across different industry verticals solve their business problems. We are always scrupulous about our work and provide customized market research reports revealing the hidden truths on different verticals like pharmaceutical, oil and gas, telecommunications, real estate, logistics, energy, healthcare, technology, FMCG, food & beverages and media sectors.

    Read More
  2. RESEARCH REPORTS

    RESEARCH REPORTS

    RESEARCH REPORTS

    Our business research and market analysis helps organizations across different industry verticals solve their business problems. We are always scrupulous about our work and provide customized market research reports revealing the hidden truths on different verticals like pharmaceutical, oil and gas, telecommunications, real estate, logistics, energy, healthcare, technology, FMCG, food & beverages and media sectors.

    Read More
  3. METHODOLOGY

    #

    METHODOLOGY

    Azoth Analytics creates in-depth research reports by recording, interpreting and analyzing information through primary and secondary research. Our strategic market sizing and data dredging techniques include secondary research, interviews with key market players and industry experts and use of industry specific statistical tools which helps in designing and planning effective research for our global and local clients.

    Read More
  4. Consulting

    #

    Consulting

    Azoth Analytics Consulting assists clients across the globe to enter, progress, and develop in the targeted market through our fact-based business intelligence. We deliver practical and implementable solutions to our domestic and international clients. Our analysts are skilled with techniques of data gathering, market sizing, forecasting, analyzing and providing competitive intelligence and provide progressive research in verticals including healthcare & pharmaceutical...

    Read More
  5. media center

    #

    media center

    Our business research and market analysis helps organizations across different industry verticals solve their business problems. We are always scrupulous about our work and provide customized market research reports revealing the hidden truths on different verticals like pharmaceutical, oil and gas, telecommunications, real estate, logistics, energy, healthcare, technology, FMCG, food & beverages and media sectors.

    Read More
news

     Home >> Research Report >> Healthcare & Pharma >> Global Pain Management Drugs Market: Analysis By Type (Opioids, NSAIDs, Anti-Migraine, Anticonvulsants), By Application, By Region, By Country: Opportunities and Forecast (2011-2021)
 

Global Pain Management Drugs Market: Analysis By Type (Opioids, NSAIDs, Anti-Migraine, Anticonvulsants), By Application, By Region, By Country: Opportunities and Forecast (2011-2021)-(By Region - N. America, Europe, APAC, Latin America, RoW; By Country - US, Canada, UK, Germany, France, Japan, China, India, Brazil, Mexico)

 
Publish Date:April 2017
No. of Pages:180
Format: Pdf (Instant Download)
 
 
Social
Electronic Access - Single User License toll
$2400
 
Electronic Access - Multi User License toll
$3000
 
Hard Copy Mail Delivery toll
$2600
 
 
Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report titled “Global Pain Management Drugs Market: Analysis By Type (Opioids, NSAIDs, Anti-Migraine, Anticonvulsants), By Application, By Region, By Country: Opportunities and Forecast (2011-2021)” aims to present the analysis of the market of pain management drugs. The global market is projected to display a robust growth represented by a CAGR of 4.96% during 2016– 2021, chiefly driven by large number of drugs in pipeline, rising number of chronically ill patients, new reforms and regulations in the consumption of medical cannabis. 

Over the recent years, the global pain management drugs industry has been growing rapidly with the increasing demand for drugs which are used for the treatment of chronic pain conditions of neck, lower back, shoulders, post-operative pain, and pain during the sports injuries. Globally, the growth in the pain management drugs market is driven by large number of chronically ill patients, rise in global incidences of cancer and strong presence of pipeline drugs used for chronically ill conditions.

According to Azoth Analytics research report, “Global Pain Management Drugs Market: Analysis By Type (Opioids, NSAIDs, Anti-Migraine, Anticonvulsants), By Application, By Region, By Country: Opportunities and Forecast (2011-2021)” the global market is projected to display a robust growth with a CAGR of 4.96% during 2016– 2021.

The report titled “Global Pain Management Drugs Market: Analysis By Type (Opioids, NSAIDs, Anti-Migraine, Anticonvulsants), By Application, By Region, By Country: Opportunities and Forecast (2011-2021)” has covered and analysed the potential of Global Pain Management Drugs Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global food service equipment market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Market (Actual Period: 2011-2015, Forecast Period: 2016E-2021F)
• Pain Management Drugs Market
• By Type of Drugs 
• Application Market
• Drug  Pipeline - By Developer, Phase, Indication and Status

Regional Markets – N. America, Europe, APAC, Latin America, RoW (Actual Period: 2011-2015, Forecast Period: 2016E-2021F)
• Pain Management Drugs Market
• By Type of Drugs  

Country Analysis - US, Canada, UK, Germany, France, Japan, China, India, Brazil, Mexico (Actual Period: 2011-2015, Forecast Period: 2016E-2021F)
• Pain Management Drugs Market

Other Report Highlights
• Market Dynamics – Trends, Drivers, Challenges
• Policy and Regulation
• Company Analysis -  Endo Pharmaceuticals, AstraZeneca, Novartis , Purdue Pharma, GSK, Tetra Bio Pharma, Allergen, Boehringer-Ingelheim, Sanofi,Pfizer

Customization of the Report
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research. 

1. Research Methodology

2. Executive Summary

3. Strategic Recommendation
3.1 Abuse Deterrent Opioids will create new growth opportunities
3.2 Developing countries will provide huge acceptance for the generic drugs

4. Pain Management Drugs Market Outlook 

5. Global Pain Management Drugs Market: Growth and Forecast
5.1 By Value (2011-2015)
5.2 By Value (2011-2015)

6. Global Pain Management Drugs Market: By Region

6.1 Global Pain Management Drugs Market Size, By Region
6.1.1 Global Pain Management Drugs Market Size, By Region, 2015(%)
6.1.2 Global Pain Management Drugs Market Size, By Region, 2021 (%)

6.2 Global Pain Management Drugs Market: By Type
6.2.1 Global Pain Management Drugs Market Size, By Type, 2015 (%)
6.2.2 Global Pain Management Drugs Market Size, By Type, 2021 (%)

6.3 Global Pain Management Drugs Market: By Application
6.3.1 Global Pain Management Drugs Market Size, By Application, 2015 (%)
6.3.2 Global Pain Management Drugs Market Size, By Application, 2021 (%)

6.4 Global Pain Management Drugs Market: By Type, NSAID 
6.4.1 By Value (2011-2015)
6.4.2 By Value (2016-2021)

6.5 Global Pain Management Drugs Market: By Type, Opioids
6.5.1 By Value (2011-2015)
6.5.2 By Value (2011-2015)

6.6 Global Pain Management Drugs Market: By Type, Antimigraine
6.6.1 By Value (2011-2015)
6.6.2 By Value (2016-2021)

6.7 Global Pain Management Drugs Market: By Type, Anticonvulsants
6.7.1 By Value (2011-2015)
6.7.2 By Value (2016-2021)

7. North America Pain Management Drugs Market
7.1 By Value (2011-2015)
7.2 By Value (2016-2021)

8. North America Pain Management Drugs Market, By Country 
8.1 North America Pain Management Drugs Market Size, By Country, 2015 (%)
8.2 North America Pain Management Drugs Market Size, By Country, 2021(%)

9. North America Pain Management Drugs Market: By Type
9.1 North America Pain Management Drugs Market Size, By Type, 2015 (%)
9.2 North America Pain Management Drugs Market Size, By Type, 2021(%)
9.3 North America Pain Management Drugs Market, By Country, By Value
9.3.1 United States Pain Management Drugs Market, By Value-(2011-2015)
9.3.2 United States Pain Management Drugs Market, By Value–(2016-2021)
9.3.3 Canada Pain Management Drugs Market, By Value-(2011-15)
9.3.4 Canada Pain Management Drugs Market, By Value–(2016-2021)

10. Europe Pain Management Drugs Market
10.1 By Value (2011-2015)
10.2 By Value (2016-2021)

11. Europe Pain Management Drugs Market, By Country
11.1 Europe Pain Management Drugs Market Size, By Country, 2015 (%)
11.2 Europe Pain Management Drugs Market Size, By Country, 2021(%)

12. Europe Pain Management Drugs Market: By Type
12.1 Europe Pain Management Drugs Market Size, By Type, 2015 (%)
12.2 Europe Pain Management Drugs Market Size, By Type, 2021(%)
12.3 Europe Pain Management Drugs Market, By Country, By Value
12.3.1 Germany Pain Management Drugs Market, By Value-(2011-2015)
12.3.2 Germany Pain Management Drugs Market, By Value–(2016-2021)
12.3.3 France Pain Management Drugs Market, By Value-(2011-2015)
12.3. France Pain Management Drugs Market, By Value–(2016-2021)
12.3.5 UK Pain Management Drugs Market, By Value-(2011-2015)
12.3.6 UK Pain Management Drugs Market, By Value-(2011-2015)

13. Asia Pacific Pain Management Drugs Management Market
13.1 By Value (2011-2015)
13.2 By Value (2016-2021)

14. Asia Pacific Pain Management Drugs Market, By Country 
14.1 Asia Pacific Pain Management Drugs Market Size, By Country, 2015 (%)
14.2 Asia Pacific Pain Management Drugs Market Size, By Country, 2021(%)

15. Asia Pacific Drug Pain Management Market: By Type
15.1 Asia Pacific   Pain Management Drugs Market Size, By Type, 2015 (%)
15.2 Asia Pacific   Pain Management Drugs Market Size, By Type, 2021)
15.3 Asia Pacific Pain Management Drugs Market, By Country, By Value
15.3.1 Japan Pain Management Drugs Market, By Value-(2011-2015)
15.3.2 Japan   Pain Management Drugs Market, By Value–(2016-2021)
15.3.3 China Pain Management Drugs Market, By Value-(2011-2015)
15.3.4 China Pain Management Drugs Market, By Value–(2016-2021)
15.3.5 India Pain Management Drugs Market, By Value-(2011-2015)
15.3.6 India Pain Management Drugs Market, By Value–(2016-2021)
   
16. Latin America Pain Management Drugs Market
16.1 By Value (2011-2015)
16.2 By Value (2016-2021)

17. Latin America Pain Management Drugs Market, By Country
17.1 Latin America Pain Management Drugs Market Size, By Country, 2015 (%)
17.2 Latin America Pain Management Drugs Market Size, By Country, 2021(%)

18. Latin America Pain Management Drugs Market: By Type  
18.1 Latin America Pain Management Drugs Market Size, By Type, 2015 (%) 
18.2 Latin America Pain Management Drugs Market Size, By Type, 2021(%)
18.3 Latin America Pain Management Drugs Market, By Country, By Value
18.3.1 Brazil Pain Management Drugs Market, By Value-(2011-2015) 
18.3.2 Brazil Pain Management Drugs Market, By Value–(2016-2021)
18.3.3 Mexico Pain Management Drugs Market, By Value-(2011-2015)
18.3.4 Mexico Pain Management Drugs Market, By Value–(2016-2021)

19. ROW Pain Management Drugs Market
19.1 By Value (2011-2015)
19.2 By Value (2016-2021)

20. Market Dynamics       
20.1 Drivers 
20.2 Challenges 
20.3 Trends

21. Company Profiles
21.1 Astrazeneca plc
21.2 Endo Pharmaceuticals
21.3 Pfizer
21.4 Novartis
21.5 Purdue Pharma
21.6 Allergan
21.7 Boehringer Ingelheim
21.8 Glaxosmithkline
21.9 Sanofi
21.10 Tetra Bio Pharma 

22. Pipeline Analysis
Figure 1: Global Pain Management Drugs Market Size, By Value, 2011-2015 (USD Billion)
Figure 2: National Healthcare Expenditure 2014-2020F
Figure 3: Medicare spending in USD Billions 
Figure 4: Number of employees (in Millions) – enrolled in Medicare Program
Figure 5: Expenditure as a percentage of GDP 
Figure 6: Global Pain Management Drugs Market Size, By Value, 2016E-2021F (USD Billion)
Figure 7: Global Pain Management Drugs Market, By Region -2015
Figure 8: Key Drivers
Figure 9: Global Pain Management Drugs Market, By Region -2021F
Figure 10: Key Drivers
Figure 11: Global Pain Management Drugs Market, By Type-2015
Figure 12: Key Drivers
Figure 13: Global Pain Management Drugs Market, By Type-2021F
Figure 14: Key Drivers
Figure 15: Global Pain Management Drugs Market, By Applications-2015
Figure 16: Key Drivers
Figure 17: Global Pain Management Drugs Market, By Applications- 2021F
Figure 18: Key Drivers
Figure 19: Global NSAID Drug Market Size, By Value, 2011-2015 (USD Billion)
Figure 20: Best Buy NSAID Drug
Figure 21: Global NSAID Drug Market Size, By Value, 2016E-2021F (USD Billion)
Figure 22: Global Medical Opioid Market Size, By Value, 2011-2015 (USD Billion)
Figure 23: United States – Hydromorphone Consumption (mg per capita)
Figure 24: United States –Fentanyl Consumption (mg per capita)
Figure 25: United States – Morphine Consumption (mg per capita)
Figure 26: United States –Methadone Consumption (mg per capita)
Figure 27: UK – Fentanyl Consumption (mg per capita)
Figure 28: UK – Hydromorphone Consumption (mg per capita
Figure 29: UK – Morphine Consumption (mg per capita)
Figure 30: UK –Methadone Consumption (mg per capita)
Figure 31: Global Medical Opioid Market Size, By Value, 2016E-2021F (USD Billion)
Figure 32: Global Anti-migraine Drug Market Size, By Value, 2011-2015 (USD Billion)
Figure 33: Europe – Impact of Migraine Annual years of Healthy Life Cost (per 100,000 of people)
Figure 34: Global Anti-Migraine Market Size, By Value, 2016E-2021F (USD Billion)
Figure 35: Global Anticonvulsants Drug Market Size, By Value, 2011-2015 (USD Billion)
Figure 36: Best Buy Anticonvulsants Drug
Figure 37: Global Anticonvulsants Drug Market Size, By Value, 2016E-2021F (USD Billion)
Figure 38: North America Pain Management Drugs Market Size, By Value, 2011-2015 (USD Billion)
Figure 39: Medicare spending in USD Billions  
Figure 40: North America Pain Management Drugs Market Size, By Value, 2016E-2021F (USD Billion)
Figure 41: North America Pain Management Drugs Market, By Country-2015
Figure 42: Key Drivers
Figure 43: North America Pain Management Drugs Market, By Country -2021
Figure 44: Key Drivers
Figure 45: North America Pain Management Drugs Market, By Type -2015
Figure 46: Key Drivers
Figure 47: North America Pain Management Drugs Market, By Type-2021
Figure 48: Key Drivers
Figure 49: United States Pain Management Drugs Market Size, By Value, 2011-2015 (USD Billion)  
Figure 50: Specialty Drug Spending in USA in USD Billion
Figure 51: Out of Pocket Expenditure in USD Billion
Figure 52: United States Pain Management Drugs Market Size, By Value, 2016-2021 (USD Billion)
Figure 53: Canada Pain Management Drugs Market Size, By Value, 2011-2015 (USD Billion)
Figure 54: Canada spending on healthcare
Figure 55: Canada spending on prescription based drugs
Figure 56: Canada Pain Management Drugs Market Size, By Value, 2016-2021 (USD Billion)
Figure 57: Europe Pain Management Drugs Market Size, By Value, 2011-2015 (USD Billion)
Figure 58: Europe Healthcare spending as percent of GDP 
Figure 59: Europe spending on prescription based drugs
Figure 60: Europe Pain Management Drugs Market Size, By Value, 2016-2021 (USD Billion)
Figure 61: Europe Pain Management Drugs Market, By Country-2015
Figure 62: Key Drivers
Figure 63: Europe Pain Management Market, By Country -2021
Figure 64: Key Drivers
Figure 65: Europe Pain Management Drugs Market, By Type -2015
Figure 66: Key Drivers
Figure 67: Europe Pain Management Drugs Market, By Type-2021
Figure 68: Key Drivers
Figure 69: Germany Pain Management Drugs Market Size, By Value, 2011-2015 (USD Billion)
Figure 70: Germany - Sales of Generic Drugs in USD Billion 
Figure 71: Germany – Percentage share of prescription drugs sold by retail pharmacy -2015
Figure 72: Germany Pain Management Drugs Market Size, By Value, 2016-2021 (USD Billion)
Figure 73: France Pain Management Drugs Market Size, By Value, 2011-2015 (USD Billion)
Figure 74: France – Percentage share of Generic drugs (By Volume) 
Figure 75: France – Percentage share of Generic drugs in Re-imbursed Pharmaceutical Market (By Value)        
Figure 76: France Pain Management Drugs Market Size, By Value, 2016-2021 (USD Billion)
Figure 77: UK Pain Management Drugs Market Size, By Value, 2011-2015 (USD Billion)
Figure 78: UK- Healthcare expenditure as percentage of GDP 
Figure 79: Key Drivers
Figure 80: UK Pain Management Drugs Market Size, By Value, 2016-2021 (USD Billion)
Figure 81: Asia Pacific Pain Management Drugs Market Size, By Value, 2011-2015 (USD Billion)
Figure 82: Asia Pacific Pain Management Drugs Market Size, By Value, 2016E-2021F (USD Billion)
Figure 83: Asia Pacific Pain Management Drugs Market, By Country-2015
Figure 84: Key Drivers
Figure 85: Asia Pacific Pain Management Drugs Market, By Country -2021
Figure 86: Key Drivers
Figure 87: Asia Pacific Pain Management Drugs Market, By Type -2015
Figure 88: Key Drivers
Figure 89: Asia Pacific Pain Management Drugs Market, By Type-2021
Figure 90: Key Drivers
Figure 91: Japan Pain Management Drugs Market Size, By Value, 2011-2015 (USD Billion) 
Figure 92: Japan- Sales of Prescription based drugs in USD Billion 
Figure 93: Japan – Opioid (Morphine) Consumption in mg per capita 
Figure 94: Japan- Fentanyl Opioid Consumption in mg per capita 
Figure 95: Japan –Oxycodone Opioid Consumption in mg per capita 
Figure 96: Japan- Fentanyl Opioid Consumption in mg per capita 
Figure 97: China Pain Management Drugs Market Size, By Value, 2011-2015 (USD Billion)
Figure 98: China – Revenue from pharmaceutical sector (in USD Billion)
Figure 99: China – Aging Population as Percentage of total population
Figure 100: China – Generic Drug Sales in RMB Billion 
Figure 101: China- Patented Drug Sales in RMB Billion 
Figure 102: China Pain Management Drugs Market Size, By Value, 2016-2021(USD Billion) 
Figure 103: China- Import and Export of Pharmaceutical Products 
Figure 104: India Pain Management Drugs Market Size, By Value, 2011-2015 (USD Billion)
Figure 105: Chronic pain in India 
Figure 106: India – Revenue from pharmaceutical sector 
Figure 107: India – Percentage Share of Pharmaceutical Segments- 2015
Figure 108: India Pain Management Drugs Market Size, By Value, 2016-2021(USD Billion)
Figure 109: Latin America Pain Management Drugs Market Size, By Value, 2011-2015 (USD Billion)
Figure 110: Latin America Pain Management Drugs Market Size, By Value, 2016-2021(USD Billion)
Figure 111: Latin America Pain Management Drugs Market, By Country-2015
Figure 112: Key Drivers
Figure 113: Latin America Pain Management Drugs Market, By Country -2021
Figure 114: Key Drivers
Figure 115: Latin America Pain Management Drugs Market, By Type -2015
Figure 116: Key Drivers
Figure 117: Latin America Pain Management Drugs Market, By Type-2021
Figure 118: Key Drivers
Figure 119: Brazil Pain Management Drugs Market Size, By Value, 2011-2015 (USD Billion)
Figure 120: Brazil – Healthcare expenditure as a percentage of GDP
Figure 121: Brazil – Percentage Share of Specialty and Traditional Medicine -2015
Figure 122: Brazil Pain Management Drugs Market Size, By Value, 2016E-2021F (USD Billion
Figure 123: Mexico Pain Management Drugs Market Size, By Value, 2011-2015 (USD Billion)
Figure 124: Mexico Pain Management Drugs Market Size, By Value, 2016E-2021F (USD Billion)
Figure 125: ROW Pain Management Drugs Market Size, By Value, 2011-2015 (USD Billion)
Figure 126: Government share in healthcare spending in GCC countries 
Figure 127: Healthcare spending in GCC Countries in USD Billion
Figure 128: South Africa - Health Financing Options in Total Healthcare Expenditure- 2015
Figure 129: ROW Pain Management Drugs Market Size, By Value, 2016E-2021F (USD Billion) 
Figure 130: Africa – Growth in Pharma Segments in USD Billion 
Figure 131: Astrazeneca Global Product Sales – By Therapy Areas - 2015
Figure 132: Astrazeneca Global Product Sales – By Therapy Areas - 2014
Figure 133: Astrazeneca Product Sales – By Geographic Markets – 2015
Figure 134: Astrazeneca Product Sales – By Geographic Markets – 2014
Figure 135: Endo Pharmaceuticals Segment Sales – 2015
Figure 136: Endo Pharmaceuticals Segment Sales – 2014
Figure 137: Pfizer Segment Sales Worldwide – 2015
Figure 138: Pfizer Segment Sales Worldwide – 2014
Figure 139: Tetra Bio Pharma Pipeline 
Figure 140: Trevena Pipeline 
One can also purchase any particular sections from this report. Please send us an email to info@azothanalytics.com with your order details.
 
 
 
 
 Latest Market Research Reports